BR9911794A - Derivados anti-histamìnicos de piperidina e intermediários para a preparação dos mesmos - Google Patents

Derivados anti-histamìnicos de piperidina e intermediários para a preparação dos mesmos

Info

Publication number
BR9911794A
BR9911794A BR9911794-0A BR9911794A BR9911794A BR 9911794 A BR9911794 A BR 9911794A BR 9911794 A BR9911794 A BR 9911794A BR 9911794 A BR9911794 A BR 9911794A
Authority
BR
Brazil
Prior art keywords
derivatives
piperidine
preparation
antihistamine
intermediates
Prior art date
Application number
BR9911794-0A
Other languages
English (en)
Inventor
Timothy Allen Ayers
Paul Wayne Brown
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22328222&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9911794(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of BR9911794A publication Critical patent/BR9911794A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C235/78—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/90—Carboxylic acid amides having nitrogen atoms of carboxamide groups further acylated
    • C07C233/91—Carboxylic acid amides having nitrogen atoms of carboxamide groups further acylated with carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Patente de Invenção: <B>"DERIVADOS ANTI-HISTAMìNICOS DE PIPERIDINA E INTERMEDIáRIOS PARA A PREPARAçãO DOS MESMOS"<D>. A invenção se refere a novos derivados de piperidina de fórmula e a um processo para preparação dos mesmos, em que R~ 1~ é H ou C~ 1~-C~ 6~ alquila, onde a porção C~ 1~-C~ 6~ alquila é de cadeia reta ou ramificada; R~ 2~ é -COOH ou -COOalquila, onde a porção alquila apresenta de 1 a 6 átomos de carbono e é de cadeia reta ou ramificada; ou estereoisómeros ou um sal de adição ácido farmaceuticamente aceitável do mesmo.
BR9911794-0A 1998-07-02 1999-06-17 Derivados anti-histamìnicos de piperidina e intermediários para a preparação dos mesmos BR9911794A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10954298A 1998-07-02 1998-07-02
PCT/US1999/013693 WO2000001671A2 (en) 1998-07-02 1999-06-17 Antihistaminic piperidine derivatives and intermediates for the preparation thereof

Publications (1)

Publication Number Publication Date
BR9911794A true BR9911794A (pt) 2001-03-27

Family

ID=22328222

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9911794-0A BR9911794A (pt) 1998-07-02 1999-06-17 Derivados anti-histamìnicos de piperidina e intermediários para a preparação dos mesmos

Country Status (20)

Country Link
EP (1) EP1091938B1 (pt)
JP (1) JP2002519411A (pt)
KR (2) KR100707904B1 (pt)
CN (3) CN100522921C (pt)
AR (1) AR019197A1 (pt)
AT (1) ATE485271T1 (pt)
AU (1) AU769284B2 (pt)
BR (1) BR9911794A (pt)
CA (1) CA2336380C (pt)
DE (1) DE69942876D1 (pt)
DK (1) DK1091938T3 (pt)
ES (1) ES2354968T3 (pt)
HU (1) HUP0104159A3 (pt)
IL (6) IL140649A0 (pt)
NO (1) NO319534B1 (pt)
NZ (2) NZ528839A (pt)
PT (1) PT1091938E (pt)
TW (1) TW533197B (pt)
WO (1) WO2000001671A2 (pt)
ZA (1) ZA200007034B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2239554T1 (es) 2002-06-10 2005-10-01 Teva Pharmaceutical Industries Ltd. Forma xvi polimorfica de hidrocloruro de fexofenadina.
CN101585768B (zh) * 2009-06-06 2012-01-04 浙江大学宁波理工学院 合成2-[4-(4-氯丁酰基)苯基]-2-甲基丙酸酯的方法
CN101585763B (zh) * 2009-06-06 2012-01-04 浙江大学宁波理工学院 一种合成2-[4-(4-氯丁酰基)苯基]-2-甲基丙酸的方法
CN101585764B (zh) * 2009-06-06 2012-02-15 浙江大学宁波理工学院 合成2—［4—(4—氯丁酰基)苯基］—2—甲基丙酸的方法
CN101585767B (zh) * 2009-06-06 2012-02-15 浙江大学宁波理工学院 一种合成2—[4—(4—氯丁酰基)苯基]—2—甲基丙酸酯的方法
EP2289867A3 (en) * 2009-08-19 2012-04-25 Jubilant Organosys Limited A process for producing 4-(4-halo-1-oxybutyl)-alpha,alpha-dimethylbenzene acetic acid or alkyl esters thereof
JP6192554B2 (ja) * 2014-02-03 2017-09-06 三菱電機株式会社 真空断熱材の製造方法
CN112661693A (zh) * 2021-01-27 2021-04-16 西北农林科技大学 一种非索非那定的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839431A (en) * 1970-07-13 1974-10-01 Squibb & Sons Inc Cyclopropylmethylphenylacetic acids and derivatives
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
ES2176201T3 (es) * 1992-04-10 2002-12-01 Merrell Pharma Inc Derivados de 4-difenilmetil piperidina y procedimiento de preparacion.
US5654433A (en) * 1993-01-26 1997-08-05 Merrell Pharmaceuticals Inc. Process for piperidine derivatives
EP0703902B1 (en) * 1993-06-24 1998-12-16 Albany Molecular Research, Inc. Process for the production of piperidine derivatives
JP3712208B2 (ja) * 1993-06-25 2005-11-02 メレルファーマスーティカルズ インコーポレイテッド 抗ヒスタミン性の４−ジフェニルメチル／ジフェニルメトキシピペリジン誘導体類を製造する新規な中間体
KR19990008406A (ko) * 1995-05-08 1999-01-25 스티븐엘.네스비트 알파-(치환된 알킬페닐)-4-(히드록시디페닐메틸)-1-피페리딘 부탄올 유도체들, 그들의 제조 방법 및 항히스타민제, 항알러지제및 기관지 확장제로서 그들의 용도

Also Published As

Publication number Publication date
EP1091938A2 (en) 2001-04-18
NO319534B1 (no) 2005-08-29
IL140649A0 (en) 2002-02-10
IL171061A (en) 2007-09-20
AR019197A1 (es) 2001-12-26
DE69942876D1 (de) 2010-12-02
HUP0104159A2 (hu) 2002-03-28
JP2002519411A (ja) 2002-07-02
DK1091938T3 (da) 2011-02-07
EP1091938B1 (en) 2010-10-20
IL171063A (en) 2007-09-20
NO20006694D0 (no) 2000-12-29
NZ508477A (en) 2003-12-19
PT1091938E (pt) 2010-12-20
AU769284B2 (en) 2004-01-22
WO2000001671A3 (en) 2000-04-06
KR100707904B1 (ko) 2007-04-16
WO2000001671A2 (en) 2000-01-13
HK1091806A1 (zh) 2007-01-26
KR20060035816A (ko) 2006-04-26
CN101311165B (zh) 2011-05-18
CA2336380A1 (en) 2000-01-13
HK1034065A1 (en) 2001-10-12
ZA200007034B (en) 2002-04-08
CN101311165A (zh) 2008-11-26
IL171062A (en) 2007-09-20
ATE485271T1 (de) 2010-11-15
CN1246312C (zh) 2006-03-22
IL140649A (en) 2006-08-01
CN1807394A (zh) 2006-07-26
AU4574699A (en) 2000-01-24
KR20010053324A (ko) 2001-06-25
NO20006694L (no) 2001-03-01
NZ528839A (en) 2005-03-24
IL171479A (en) 2007-10-31
CN1308611A (zh) 2001-08-15
CN100522921C (zh) 2009-08-05
HUP0104159A3 (en) 2002-04-29
HK1125382A1 (en) 2009-08-07
CA2336380C (en) 2007-04-10
TW533197B (en) 2003-05-21
KR100682447B1 (ko) 2007-02-16
ES2354968T3 (es) 2011-03-21

Similar Documents

Publication Publication Date Title
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
DE69919212D1 (de) Aromatische amiden
BR9907300A (pt) Inibidores do fator xa oxoaza-heterociclila substituìdos
BR9913592A (pt) Compostos, processo de preparação dos compostos, e, composições farmacêuticas
BR0210842A (pt) Processo para a preparação de intermediários úteis na sìntese de derivados de estatina, especialmente derivados do ácido 7-amino 3,5-dihidróxi heptanóico, e intermediários dos mesmos
NO307463B1 (no) Galantaminderivater, en fremgangsmõte for fremstilling samt deres anvendelse som medikamenter
NO973363D0 (no) Neuraminsyrederivater, deres fremstilling og medisinske bruk
BR9911794A (pt) Derivados anti-histamìnicos de piperidina e intermediários para a preparação dos mesmos
PT865498E (pt) Processo para a preparacao de ciclodepsipeptideos com 24 atomos no anel substituidos contendo acido aril-lactico
BR9905089A (pt) Derivados macrolìdeos
PT1043310E (pt) Derivados de bifenilamidina
BR0308027A (pt) Processo para preparação de um derivado de fenilalanina e seus intermediários
BR0114367A (pt) Processo para a preparação de um composto, e, composto
PT1303514E (pt) Processo para preparacao de azacicloalcanoilaminotiazoles
PT97032A (pt) Processo para a preparacao de derivado do acido (benzidriloxi-etilpiperidil)-alifatico utilizaveis como agente anti-histaminicos
BR9913598A (pt) Inibidores de protease de hiv
PT1347960E (pt) Processo para a preparacao de (+)-trans-4-p-fluorofenil-3-hidroximetil-1-metilpiperidina
BR0100650A (pt) Processo de alquilação e hidroxifenilbenzotriazóis
BR0110642A (pt) Processo para preparação de sais de sulfonilbenzoilguanidìnio
BR0010231A (pt) Derivados de halo de 9a-n-(n&#39;-larilcarbamoil)- e 9a-n-(n&#39;l- ariltiocarbamoil)-9-desoxo-9a-aza-9a-homoeritromici na a
BRPI0411772A (pt) uso de derivados de biciclo[2.2.1]heptano para o preparo de composições farmacêuticas neuroprotetoras
BR9908765A (pt) Processo para a preparação do tetrapeptìdeo h-tyr-d-ala-phe(f)-phe-nh2, peptìdeo, e derivado de peptìdeo
BR0004578A (pt) Processo de acilação
BR9910603A (pt) Método aprimorado paraa preparar derivados de norbenzomorfano valiosos farmaceuticamente
BR0013094A (pt) Processo para a preparação de compostos 1,3-dicarbonìlicos acilados

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: C07D 211/22, A61K 31/445, A61P 37/08, C07D 211/00, C07C 67/333, C07C 69/713, C07C 69/738, C07C 259/06

Ipc: C07D 211/00 (2009.01)

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIDO O PEDIDO COM BASE NOS ARTIGOS 8O, 10(VIII), 11 E 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B25A Requested transfer of rights approved

Owner name: HMR PHARMA, INC. (US)

Free format text: TRANSFERIDO DE: AVENTIS PHARMACEUTICALS, INC.

B25A Requested transfer of rights approved

Owner name: AVENTIS HOLDINGS INC. (US)

Free format text: TRANSFERIDO DE: HMR PHARMA, INC.

B25A Requested transfer of rights approved

Owner name: AVENTISUB II INC. (US)

Free format text: TRANSFERIDO DE: AVENTIS HOLDINGS INC.